Skip to main page content
U.S. flag

An official website of the United States government

Dot gov

The .gov means it’s official.
Federal government websites often end in .gov or .mil. Before sharing sensitive information, make sure you’re on a federal government site.

Https

The site is secure.
The https:// ensures that you are connecting to the official website and that any information you provide is encrypted and transmitted securely.

Access keys NCBI Homepage MyNCBI Homepage Main Content Main Navigation

Search Page

Filters

My NCBI Filters

Results by year

Table representation of search results timeline featuring number of search results per year.

Year Number of Results
1996 1
2000 1
2004 1
2005 1
2007 1
2008 1
2009 1
2024 0

Text availability

Article attribute

Article type

Publication date

Search Results

6 results

Results by year

Filters applied: . Clear all
Page 1
Treatment of hormone-refractory prostate carcinoma.
Fournier G. Fournier G. Eur Urol. 1996;30 Suppl 1:32-7. doi: 10.1159/000474243. Eur Urol. 1996. PMID: 8977988 Review.
OBJECTIVES: To review the treatment of hormone-refractory prostate cancer (HRPC). INTRODUCTION: Almost all patients with metastatic prostatic cancer will eventually escape the control of the first-line endocrine therapy, and relapse. ...Finally, other palliat …
OBJECTIVES: To review the treatment of hormone-refractory prostate cancer (HRPC). INTRODUCTION: Almost all patients with metas …
Weekly administration of docetaxel and epirubicin as first-line treatment for hormone-refractory prostate carcinoma.
Neri B, Molinara E, Pantaleo P, Rangan S, Crisci A, Della Melina A, Raugei A, Villari D, Nicitat G. Neri B, et al. Oncol Res. 2009;17(11-12):565-70. doi: 10.3727/096504009789745539. Oncol Res. 2009. PMID: 19806787
Androgen-independent prostate carcinoma (AICP) is one of the tumors that continue to respond poorly to chemotherapy. ...Nineteen patients (56%) experienced PSA reductions of >50% that persisted for more than 4 weeks. The response to therapy was classified …
Androgen-independent prostate carcinoma (AICP) is one of the tumors that continue to respond poorly to chemotherapy. ...Ninete …
Society of Urologic Oncology position statement: redefining the management of hormone-refractory prostate carcinoma.
Chang SS, Benson MC, Campbell SC, Crook J, Dreicer R, Evans CP, Hall MC, Higano C, Kelly WK, Sartor O, Smith JA Jr; Society of Urologic Oncology, Shaumberg, Illinois. Chang SS, et al. Cancer. 2005 Jan 1;103(1):11-21. doi: 10.1002/cncr.20726. Cancer. 2005. PMID: 15558815 Free article.
Because patients with hormone-refractory prostate carcinoma are a very diverse group, management of these patients represents a unique challenge. ...Although significant progress has been made in understanding and treating hormone-refractory prostat …
Because patients with hormone-refractory prostate carcinoma are a very diverse group, management of these patients repr …
Contemporary chemotherapeutic approaches for the treatment of hormone-refractory prostate carcinoma.
Walther PJ. Walther PJ. World J Urol. 2000 Jun;18(3):216-21. doi: 10.1007/s003450000126. World J Urol. 2000. PMID: 10926086 Review.
The medical management of hormone-refractory prostate cancer remains difficult and largely palliative. ...Benefiting from new molecular-biologic insights into the pathobiology of prostate cancer, novel strategies targeting new molecular pathways of cell regul …
The medical management of hormone-refractory prostate cancer remains difficult and largely palliative. ...Benefiting from new …
Ionizing radiation causes a dose-dependent release of transforming growth factor alpha in vitro from irradiated xenografts and during palliative treatment of hormone-refractory prostate carcinoma.
Hagan M, Yacoub A, Dent P. Hagan M, et al. Clin Cancer Res. 2004 Sep 1;10(17):5724-31. doi: 10.1158/1078-0432.CCR-04-0420. Clin Cancer Res. 2004. PMID: 15355899
Ionizing irradiation also results in the release of TGF alpha for patients undergoing radiation therapy for hormone-refractory prostate cancer. CONCLUSIONS: Irradiation results in a dose-dependent increase in TGF alpha capable of enhancing the growth of DU145 …
Ionizing irradiation also results in the release of TGF alpha for patients undergoing radiation therapy for hormone-refractory …
Quality of analgesic treatment in patients with advanced prostate cancer: do we do a better job now? The Swiss Group for Clinical Cancer Research (SAKK) experience.
Münger-Beyeler C, Bernhard J, Rufibach K, Morant R, Schmid HP. Münger-Beyeler C, et al. Support Care Cancer. 2008 May;16(5):461-7. doi: 10.1007/s00520-007-0335-7. Epub 2007 Oct 2. Support Care Cancer. 2008. PMID: 17909864 Free article.
GOALS OF WORK: The aim of this study was to evaluate pain intensity and the application of the WHO guidelines for cancer pain treatment in patients with prostate cancer treated at Swiss cancer centers. MATERIALS AND METHODS: We analyzed a series of five multicenter phase I …
GOALS OF WORK: The aim of this study was to evaluate pain intensity and the application of the WHO guidelines for cancer pain treatment in p …